跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
专注达 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Methylphenidate Hydrochloride Prolonged-Release Tablets
Approved
化学药品
Methylphenidate Hydrochloride Prolonged-Release Tablets
Janssen-Cilag Manufacturing, LLC
🇨🇳 National Medical Products Administration
Approval Date
Aug 31, 2017
Approval ID
7MazXbyY1PI
Company
Janssen-Cilag Manufacturing, LLC
Type
化学药品
Approval Details
Approval Id
7MazXbyY1PI
Approval Number
国药准字J20171050
Generic Name
盐酸哌甲酯缓释片
Generic Name En
Methylphenidate Hydrochloride Prolonged-Release Tablets
Trade Name
专注达
Drug Type
化学药品
Dosage Form
片剂
Strength
15片/瓶
Reg Date
2017-08-31
Company Name
Janssen-Cilag Manufacturing, LLC
Company Address
920 U.S. Route 202, P.O. Box 300, Raritan, NJ 08869, United States of America
Production Company Name
Janssen-Cilag Manufacturing, LLC
Production Company Address
State Road 933, KM 0.1, Mamey Ward, Gurabo, PUERTO RICO 00778, United States (USA)
Company Detail Path
/organization/janssen-cilag-manufacturing-llc
Production Company Detail Path
/organization/janssen-cilag-manufacturing-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 31, 2017
Approval ID
7MazXbyY1PI
Type
化学药品
Back to NMPA Approvals